期刊文献+

复方阿嗪米特肠溶片联合多潘立酮治疗功能性消化不良疗效观察 被引量:4

Effect of complex Azintamide Enteric tablet combined with Domperidone on patients with functional dyspepsia
下载PDF
导出
摘要 目的:观察复方阿嗪米特肠溶片联合多潘立酮治疗功能性消化不良(FD)的临床疗效。方法:75例功能性消化不良患者随机分治疗组40例,对照组35例。两组均应用多潘立酮片10mg/次,3次/d,餐前30min服。治疗组在应用多潘立酮的基础上加服复方阿嗪米特肠溶片,2粒/次,3次/d,餐后服用。疗程均为4周,观察临床症状变化及缓解情况。结果:治疗组症状缓解总有效率达95%,与对照组总有效率80%比较差异有统计学意义(P<0.05)。结论:复方阿嗪米特肠溶片联合多潘立酮治疗功能性消化不良(FD)疗效较好且安全,临床疗效优于单用多潘立酮。 Objetive:To investigate the clinical efficacy of complex Azintamide Enteric tablet combined with Domperidone in functional dyspepsia.Methods: 75 patients were divided into two groups randomly,complex Azintamide Enteric tablet combined with Domperidone treatment group(40 patients),and control group(35 patients).Patients of the two groups took Dompridone(10mg)30minutes before meals,Tid for 4 weeks.Meanwhile patients in the treatment group were given 2 complex Azintamide Enteric tablets after meals,Tid.The changes of clinical symptoms and progress of relief were recorded.Results:The total effective rate of symptom relief in the treatment group was 95%,compared to the 80% in control group.There was significantly statistical difference(P0.05).Conclusions:Complex Azintamide Enteric tablet combined with Domperidone is safe in the treatment of functional dyspepsia,and more effective than Domperidone only.
出处 《华夏医学》 CAS 2010年第6期733-735,共3页 Acta Medicinae Sinica
关键词 功能性消化不良 复方阿嗪米特 多潘立酮 functional dyspepsia complex Azintamide Enteric tablet Domperidone
  • 相关文献

参考文献2

二级参考文献7

  • 1Andersen BN, Scheel J, Rune SJ, Worning H. Exocrine pancreatic function in patients with dyspepsia. Hepatogastroenterology, 1982, 29: 35~37.
  • 2Alvisi V, Bettini L, Blasi A, D'Arienzo A, D'Ambrosi A,Di Simone A, Mangiameli A, Muiesan G, Esposito P,Sollazzo R. Analysis of the symptomatologic components of dyspepsia and their response to treatment with different preparations of ursodeoxycholic acid. Controlled multicenter study. Clin Ter, 1983, 107: 291~295.
  • 3HoltmannG, Gschossmann J, Mayr P, Talley NJ. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther, 2002, 16:1641 ~1648.
  • 4Salvioli G, Carati L, Lugli R. Steatorrhoea in cirrhosis:effect of ursodeoxycholic acid administration. J Int Med Res, 1990, 18: 289~297.
  • 5Salen G. Clinical perspective on the treatment of gallstones with ursodeoxycholic acid. J Clin Gastroenterol,1988, 10 Suppl 2: S12~S17.
  • 6Suarez F, Levitt MD, Adshead J, Barkin JS. Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal. Dig Dis Sci, 1999, 44: 1317~1321.
  • 7Talley NJ. Dyspepsia management in the millennium: the death of test and treat? Gastroenterology, 2002, 122:1521~1525.

共引文献103

同被引文献40

引证文献4

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部